EVs derived from glioblastoma cells carrying mutant epidermal growth factor receptor (EGFR) variant III (EGFRvIII) transcripts were found to stimulate tubule formation in ex vivo angiogenesis assays, although the role of EGFRvIII was not explicitly documented in this setting [110]. The gene discussed is EGFR; the disease is glioblastoma.